27,588 reported events
Top reactions: Lack of efficacy - NOS (3,576) · Vomiting (3,211) · INEFFECTIVE, ATOPY CONTROL (2,677) · Diarrhoea (2,177) · Lethargy (see also Central nervous system depression in 'Neurological') (2,085)
5 authorised products across national registers.
United States — DailyMed (NLM)
Australia — APVMA PUBCRIS
United Kingdom — VMD
No residue limits (MRL) are recorded for this substance.
No antimicrobial-resistance surveillance is recorded for this substance.
Spontaneous adverse-event reports that name Oclacitinib Maleate, by species — reported counts, not proven reactions.
Top reactions: Lack of efficacy - NOS (3,576) · Vomiting (3,211) · INEFFECTIVE, ATOPY CONTROL (2,677) · Diarrhoea (2,177) · Lethargy (see also Central nervous system depression in 'Neurological') (2,085)
Top reactions: Accidental exposure (107) · Vomiting (71) · Lack of efficacy - NOS (63) · Lethargy (see also Central nervous system depression in Neurological) (58) · Overdose (57)
Source: openFDA Animal & Veterinary adverse-event reports.
Reading about Oclacitinib Maleate? Pet products get recalled all the time — get a free email when a new pet-relevant recall is published. Unsubscribe any time.
Opt-in only: we store your email, language, optional species filter and the page you signed up on, and send a welcome email with a one-click unsubscribe link. We never share your address.